913388-75-7 Usage
Molecular structure
1H-Indole-1-carboxylic acid, 2-borono-5-(4-methyl-1-piperazinyl)-, 1-(1,1-dimethylethyl) ester is a chemical compound with a unique structure that includes a boron-containing moiety and a 1-(1,1-dimethylethyl) ester group.
Application
This compound is commonly used in the field of pharmaceuticals and medicinal chemistry, often serving as an intermediate in the synthesis of various pharmaceutical drugs.
Unique properties
The boron-containing moiety gives the compound the ability to form stable complexes with biological molecules, making it a valuable tool in drug discovery and development.
Stability and solubility
The 1-(1,1-dimethylethyl) ester group enhances the stability and solubility of the compound, making it a versatile building block for the synthesis of bioactive molecules.
Potential for further research
1H-Indole-1-carboxylic acid, 2-borono-5-(4-methyl-1-piperazinyl)-, 1-(1,1-dimethylethyl) ester is a key component in the production of pharmaceuticals and holds potential for further research and applications in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 913388-75-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,3,8 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 913388-75:
(8*9)+(7*1)+(6*3)+(5*3)+(4*8)+(3*8)+(2*7)+(1*5)=187
187 % 10 = 7
So 913388-75-7 is a valid CAS Registry Number.
InChI:InChI=1/C18H26BN3O4/c1-18(2,3)26-17(23)22-15-6-5-14(21-9-7-20(4)8-10-21)11-13(15)12-16(22)19(24)25/h5-6,11-12,24-25H,7-10H2,1-4H3
913388-75-7Relevant articles and documents
JAK INHIBITOR
-
Page/Page column 86, (2009/10/21)
A JAK inhibitor comprising, as an active ingredient, a nitrogen-containing heterocyclic compound represented by formula (I) {wherein W represents a nitrogen atom or -CH-; X represents -C (=O) - or -CHR4- (wherein R4 represents a hydrogen atom, or the like); R1 represents the formula described below [wherein Q1 represents-CR8-(wherein R8 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); Q2 represents -NR15- (wherein R15 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); and R5 and R6 may be the same or different and each represents a hydrogen atom, halogen, carboxy, substituted or unsubstituted lower alkyl, or the like], or the like; and R2 and R3 may be the same or different and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, or the like} or a pharmaceutically acceptable salt thereof.
